A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

Trial Identifier: D601HC00006
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04959266
Start Date: June 2021
Primary Completion Date: June 2022
Study Completion Date: June 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish Translation
Spanish (US) Translation

Trial Locations

Country Location
ES Barcelona, ES, 08023
ES Madrid, ES, 28031
ES Madrid, ES, 28029
ES Madrid, ES, 28040
ES Madrid, ES, 28034
ES Madrid, ES, 28041
ES Malaga, ES, 29010
ES Pozuelo de Alarcon, ES, 28223
US, CT New Haven, CT, US, 06510
US, GA Newnan, GA, US, 30265
US, NH Lebanon, NH, US, 03756
US, OR Portland, OR, US, 97213
US, TX Austin, TX, US, 78758
US, TX Dallas, TX, US, 75230